LENZ Therapeutics, Inc. financial data

Symbol
LENZ on Nasdaq
Location
201 Lomas Santa Fe Drive, Suite 300, Solana Beach, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Jul 30, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.28K % +84.5%
Debt-to-equity 4.91 % -89.9%
Return On Equity -25.6 % +78.9%
Return On Assets -24.4 % +33.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28.5M shares +3.73%
Common Stock, Shares, Outstanding 28.5M shares +10.3%
Entity Public Float 363M USD +140%
Common Stock, Value, Issued 1K USD
Weighted Average Number of Shares Outstanding, Basic 28.1M shares +9.65%
Weighted Average Number of Shares Outstanding, Diluted 28.1M shares +9.65%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 27.2M USD -49.7%
General and Administrative Expense 41M USD +24.7%
Operating Income (Loss) -62M USD +17.7%
Nonoperating Income (Expense) 10.1M USD +78.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -14.4M USD -40.6%
Income Tax Expense (Benefit) 500K USD
Net Income (Loss) Attributable to Parent -52.4M USD +24.6%
Earnings Per Share, Basic 0 USD/shares -32.5%
Earnings Per Share, Diluted 0 USD/shares -32.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 37.6M USD -55.2%
Cash, Cash Equivalents, and Short-term Investments 210M USD +6.88%
Assets, Current 214M USD +7.15%
Property, Plant and Equipment, Net 1.17M USD +613%
Operating Lease, Right-of-Use Asset 959K USD -44.5%
Other Assets, Noncurrent 1.6M USD +14.6%
Assets 217M USD +7.25%
Accounts Payable, Current 2.85M USD -35.2%
Employee-related Liabilities, Current 2.94M USD +89.5%
Accrued Liabilities, Current 7.54M USD +80.6%
Liabilities, Current 10.4M USD +21.1%
Operating Lease, Liability, Noncurrent 569K USD -45.9%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 11M USD +12.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 38K USD
Retained Earnings (Accumulated Deficit) -175M USD -42.9%
Stockholders' Equity Attributable to Parent 206M USD +6.97%
Liabilities and Equity 217M USD +7.25%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16M USD +33%
Net Cash Provided by (Used in) Financing Activities 171M USD +106%
Net Cash Provided by (Used in) Investing Activities 18.9M USD +4.94%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 28.5M shares +10.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.88M USD -98.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 37.7M USD -55.2%
Deferred Tax Assets, Valuation Allowance 53.2M USD +98.9%
Deferred Tax Assets, Gross 53.8M USD +101%
Operating Lease, Liability 1.05M USD -29%
Depreciation 2.4M USD 0%
Payments to Acquire Property, Plant, and Equipment 110K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -52.3M USD +24.8%
Lessee, Operating Lease, Liability, to be Paid 1.15M USD -31.6%
Property, Plant and Equipment, Gross 719K USD +788%
Operating Lease, Liability, Current 482K USD -25.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 511K USD -11.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 274K USD +20.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 95K USD -51.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 361K USD -29.4%
Deferred Tax Assets, Operating Loss Carryforwards 15.5M USD +291%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 4.28M USD +119%
Lessee, Operating Lease, Liability, to be Paid, Year Four 361K USD -95.7%
Operating Lease, Payments 1.75M USD +32.5%
Additional Paid in Capital 381M USD +20.9%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 36K USD +620%
Deferred Tax Assets, Net of Valuation Allowance 620K USD +738%
Share-based Payment Arrangement, Expense 9.22M USD +159%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%